Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,662 public trials 323 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

A Study of Tanespimycin (KOS-953) in Patients With Relapsed-refractory Multiple Myeloma

NCT00514371

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution Berkeley, California, United States
  • Local Institution San Francisco, California, United States
  • Local Institution Augusta, Georgia, United States
  • Local Institution Baltimore, Maryland, United States
View Trial Details
Completed

Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy

NCT00002850

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Cedar Rapids Oncology Associates Cedar Rapids, Iowa, United States
  • McCreery Cancer Center at Ottumwa Regional Ottumwa, Iowa, United States
View all 45 locations
View Trial Details
Completed

Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma

NCT00103506

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Alabaster, Alabama, United States
  • Surprise, Arizona, United States
  • Berkeley, California, United States
  • Loma Linda, California, United States
View all 108 locations
View Trial Details

Related conditions